View document text
June 19, 2026
To To
The Secretary, The Manager,
Listing Department, Listing Department,
BSE Limited, The National Stock Exchange of India Ltd,
1st Floor, Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex,
Dalal Street, Mumbai 400001. Bandra (East), Mumbai 400051.
Scrip Code: 540975 Scrip Symbol: ASTERDM
Dear Sir/ Madam,
Sub: Intimation of order passed by the Hon’ble National Company Law Tribunal, Hyderabad Bench,
approving the Scheme of Amalgamation
Ref: Our letter dated April 2, 2026, and Regulation 30 read with Schedule III of SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)
Further to our letter dated April 2, 2026, on the above subject, we wish to inform you that the Hon’ble
National Company Law Tribunal, Hyderabad Bench ("NCLT") has sanctioned the Scheme of
Amalgamation between Quality Care India Limited (“QCIL” / “Transferor Company”) and Aster DM
Healthcare Limited (“Aster DM” / “Transferee Company”) and their respective shareholders and
creditors under Section 230 to 232 and other applicable provisions of the Companies Act, 2013 by its
order passed today i.e., 19 June 2026. A certified copy of the NCLT Order is awaited.
The Scheme shall become effective upon filing the certified copy of the aforesaid order with the
Registrar of Companies by the respective companies and satisfaction of other conditionalities
mentioned in the Scheme. Upon the Scheme becoming effective, QCIL shall stand being dissolved
without winding up. The Company will intimate the Effective Date to the Stock Exchanges in due
course.
We request you to kindly take the above information on record.
Thanking you.
For Aster DM Healthcare Limited
Hemish Purushottam
Company Secretary and Compliance Officer
M. No. A24331